🇺🇸 FDA
Patent

US 6183752

Restenosis/atherosclerosis diagnosis, prophylaxis and therapy

expired A61KA61K2039/5256A61K2039/58

Quick answer

US patent 6183752 (Restenosis/atherosclerosis diagnosis, prophylaxis and therapy) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/5256, A61K2039/58, A61K39/00, A61K39/001151